Blog
Best Value Stock to Buy for Nov. 20th
Here are two stocks with buy rank and strong value characteristics for investors to consider today, Nov. 20th:
Millicom International Cellular TIGO: This leading international operator of cellular
Pinterest Rides on Solid ARPU Growth: Will the Uptrend Continue?
Pinterest, Inc. PINS is witnessing solid growth in average revenue per user across multiple regions. In the third quarter, global average revenue per user (ARPU) stood at $1.78 compared with the
Company News for Nov 20, 2025
- Shares of Dolby Laboratories, Inc. (DLB) rose 0.1% after the company reported fourth-quarter fiscal 2025 earnings of $0.99 per share, beating the Zacks Consensus Estimate of $0.7 per share.
Wall Street Analysts Think O-I Glass (OI) Could Surge 30.39%: Read This Before Placing a Bet
O-I Glass (OI) closed the last trading session at $12.7, gaining 3.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Think Ocular Therapeutix (OCUL) Could Surge 82.48%: Read This Before Placing a Bet
Shares of Ocular Therapeutix (OCUL) have gained 6.7% over the past four weeks to close the last trading session at $12.1, but there could still be a solid upside left in the stock if short-term
Can SiTime (SITM) Climb 28.17% to Reach the Level Wall Street Analysts Expect?
Shares of SiTime (SITM) have gained 1.8% over the past four weeks to close the last trading session at $270.3, but there could still be a solid upside left in the stock if short-term price targets
Wall Street Analysts See a 33.5% Upside in El Pollo Loco (LOCO): Can the Stock Really Move This High?
Shares of El Pollo Loco Holdings (LOCO) have gained 7.1% over the past four weeks to close the last trading session at $10.24, but there could still be a solid upside left in the stock if short-term
Wall Street Analysts Believe On Holding (ONON) Could Rally 40.14%: Here's is How to Trade
On Holding (ONON) closed the last trading session at $43.3, gaining 2.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts Believe EverQuote (EVER) Could Rally 41.77%: Here's is How to Trade
Shares of EverQuote (EVER) have gained 18.2% over the past four weeks to close the last trading session at $23.75, but there could still be a solid upside left in the stock if short-term price
F&G Annuities & Life, Inc. (FG) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
The price trend for F&G Annuities & Life, Inc. (FG) has been bearish lately and the stock has lost 9.1% over the past week. However, the formation of a hammer chart pattern in its last trading
Wall Street Analysts Predict a 39.39% Upside in Seanergy Maritime Holdings (SHIP): Here's What You Should Know
Seanergy Maritime Holdings Corp (SHIP) closed the last trading session at $9.24, gaining 13.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
Wall Street Analysts Believe Customers Bancorp (CUBI) Could Rally 30.38%: Here's is How to Trade
Shares of Customers Bancorp (CUBI) have gained 1.6% over the past four weeks to close the last trading session at $65, but there could still be a solid upside left in the stock if short-term price
Here's Why Amazon (AMZN) Looks Ripe for Bottom Fishing
A downtrend has been apparent in Amazon (AMZN) lately. While the stock has lost 8.8% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last trading
NCLH Hits $1B in Quarterly EBITDA: Peak Performance or Just the Start?
Norwegian Cruise Line Holdings Ltd. NCLH delivered a milestone performance in third-quarter 2025, surpassing the $1 billion mark in adjusted EBITDA for the first time in company history. The result
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The popular research
Why UBS (UBS) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service
Why OneMain Holdings (OMF) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Why Incyte (INCY) is a Top Momentum Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Here's Why Newmont Corporation (NEM) is a Strong Momentum Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Here's Why Agnico Eagle Mines (AEM) is a Strong Momentum Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Here's Why Alphabet (GOOGL) is a Strong Momentum Stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The popular research
MRK HIV Regimen Meets Goal in New Study, Gains EU Nod for Keytruda SC
Merck MRK announced positive top-line results from a pivotal late-stage study evaluating its investigational, once-daily, oral, two-drug, single-tablet regimen of doravirine/islatravir [DOR/ISL (100
Zacks Initiates Coverage of INTG With Underperform Recommendation
Zacks Investment Research has recently initiated coverage of The InterGroup Corporation INTG with an Underperform recommendation, reflecting the firm’s cautious stance on the company’s ability to


